In non-small-cell lung cancer, Inoue et al. proved that both PDL1 amplification and the level of protein expression were predictors of poor survival [31], while Koh et al. did not find any association between PDL1 expression and OS or relapse-free survival (RFS) rate [17]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.